For the Inventor, By the Inventor

Enter assignee name

County Cork, Ireland

Janssen Sciences Ireland Uc

USPTO Granted Patents = 111

% Expired Patents = 46.8

CIPO Patents = 24

EPO Patents = 62

Trademarks = 5

Forward Citations = 546

Loading Chart...

Loading Chart...

140 inventors (with patents filed for the assignee):

Pierre Jean-Marie Bernard Raboisson (71 out of 178 patents)

Tim Hugo Maria Jonckers (35 out of 78 patents)

Abdellah Tahri (24 out of 61 patents)

4. David Craig McGowan (23 out of 62 patents)

5. Stefaan Julien Last (23 out of 37 patents)

6. Koen Vandyck (21 out of 46 patents)

7. Sandrine Marie Helene Vendeville (19 out of 41 patents)

8. Lili Hu (18 out of 37 patents)

9. Magali Madeleine Simone Motte (15 out of 25 patents)

10. Samuël Dominique Demin (13 out of 16 patents)

11. Ludwig Paul Cooymans (12 out of 25 patents)

12. Anil Koul (12 out of 31 patents)

13. Werner Embrechts (12 out of 18 patents)

14. Wendy Mia Albert Balemans (12 out of 19 patents)

15. Jerôme Emile Georges Guillemont (12 out of 27 patents)

Core Competencies:

Antiviral

HIV

Hepatitis B

Pyrimidine Derivatives

Heterocyclic Compounds

Antibacterial

RSV

Formulations

Inhibitors

Therapeutic Compositions

Viral Infections

111 patents: Sort by Forward Citations

1. 12011506 - Combination and uses and treatments thereof (2024-06-18),

2. 11654150 - Darunavir combination formulations (2023-05-23),

3. 11541050 - Pyrimidine derivatives for the treatment of viral infections (2023-01-03),

4. 11180472 - Antibacterial compounds (2021-11-23),

5. 11179396 - Heterocyclic compounds as antibacterials (2021-11-23),

6. 11078193 - Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2021-08-03),

7. 10995064 - Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B (2021-05-04),

8. 10941113 - Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B (2021-03-09),

9. 10875876 - Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2020-12-29),

10. 10857102 - Therapeutic compositions comprising rilpivirine HCL and tenofovir disoproxil fumarate (2020-12-08),

11. 10786518 - Compositions and methods of treating HIV (2020-09-29),

12. 10780089 - Pyrimidine derivatives for the treatment of viral infections (2020-09-22),

13. 10676429 - Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B (2020-06-09),

14. 10626108 - Heterocyclic indoles for use in influenza virus infection (2020-04-21),

15. 10611755 - Aryl substituted pyrimidines for use in influenza virus infection (2020-04-07),

Janssen Sciences Ireland Uc, located in County Cork, specializes in the development of antiviral compounds, focusing on innovative treatments for viral infections such as HIV and Hepatitis B. The company is engaged in advanced research on pyrimidine derivatives and heterocyclic compounds, contributing to the formulation of effective antiviral and antibacterial therapies. With a commitment to addressing unmet medical needs, Janssen leverages its expertise to enhance patient outcomes in infectious diseases.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Janssen Sciences Ireland Uc

111 Patents

#1 in County Cork

#30 in Ireland

#7,103 in the World

County Cork, Ireland

Janssen Sciences Ireland Uc

Forward Citations = 546

140 inventors:

Pierre Jean-Marie Bernard Raboisson (71 out of 178 patents)

Tim Hugo Maria Jonckers (35 out of 78 patents)

Abdellah Tahri (24 out of 61 patents)

4. David Craig McGowan (23 out of 62 patents)

5. Stefaan Julien Last (23 out of 37 patents)

Please report any incorrect information to [email protected]

Loading…